We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+3.96%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$15.8B
AUM Growth
+$600M
(+4%)
Cap. Flow
+$62.2M
Cap. Flow
% of AUM
0.39%
Top 10 Holdings %
Top 10 Hldgs %
39.24%
Holding
1,522
New
71
Increased
243
Reduced
326
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$93.8M |
| 2 |
Zimmer Biomet
ZBH
|
+$62.6M |
| 3 |
Gilead Sciences
GILD
|
+$35.1M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$25.2M |
| 5 |
Honeywell
HON
|
+$17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$90.2M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$33.6M |
| 3 |
AstraZeneca
AZN
|
+$23.3M |
| 4 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$20.1M |
| 5 |
Innoviva
INVA
|
+$19.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.27% |
| 2 | Healthcare | 11.8% |
| 3 | Industrials | 8.53% |
| 4 | Technology | 7.67% |
| 5 | Energy | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Target
TGT
$61.1B
| $40M | 0.25% |
691,069
-235,808
| -25% | -$13.9M |
|
77
Ingredion
INGR
$6.32B
| $39.8M | 0.25% |
530,318
-6,721
| -1% | -$489K |
|
78
Walt Disney
DIS
$161B
| $39.3M | 0.25% |
457,916
-7,619
| -2% | -$622K |
|
79
Brookfield Infrastructure Partners
BIP
$18.9B
| $38.3M | 0.24% |
2,311,722
-5,851
| -0.3% | -$93.7K |
|
80
AbbVie
ABBV
$454B
| $37.4M | 0.24% |
661,996
+74,677
| +13% | +$3.92M |
|
81
Abbott
ABT
$175B
| $36.6M | 0.23% |
895,357
+170,083
| +23% | +$6.68M |
|
|
TECD
82
DELISTED
Tech Data Corp
TECD
| $36M | 0.23% |
576,083
| – | – |
|
83
Western Union
WU
$2.6B
| $35.8M | 0.23% |
2,064,282
-50,365
| -2% | -$814K |
|
|
PX
84
DELISTED
Praxair Inc
PX
| $35.7M | 0.23% |
268,640
-17,670
| -6% | -$2.32M |
|
85
Amgen
AMGN
$201B
| $35.5M | 0.22% |
299,528
+1,267
| +0.4% | +$147K |
|
86
Darden Restaurants
DRI
$22.2B
| $35.3M | 0.22% |
854,058
-26,938
| -3% | -$1.19M |
|
87
UnitedHealth
UNH
$385B
| $33.5M | 0.21% |
410,355
-58,662
| -13% | -$4.62M |
|
|
DNB
88
DELISTED
Dun & Bradstreet
DNB
| $32.8M | 0.21% |
297,504
-1,165
| -0.4% | -$122K |
|
89
Mondelez International
MDLZ
$77.1B
| $32.6M | 0.21% |
866,678
-1,221
| -0.1% | -$44.6K |
|
90
Moody's
MCO
$82.5B
| $32M | 0.2% |
364,914
-4,311
| -1% | -$355K |
|
91
Minerals Technologies
MTX
$2.27B
| $31.6M | 0.2% |
481,484
-4,350
| -0.9% | -$272K |
|
|
QVCGA
92
DELISTED
QVC Group Inc Series A
QVCGA
| $31.2M | 0.2% |
25,855
-1,938
| -7% | -$2.31M |
|
93
Teva Pharmaceuticals
TEVA
$36.3B
| $30.8M | 0.2% |
587,755
-2,765
| -0.5% | -$141K |
|
94
The Mosaic Company
MOS
$7.08B
| $30.1M | 0.19% |
608,230
-13,201
| -2% | -$650K |
|
95
Capital Southwest
CSWC
$1.46B
| $29.1M | 0.18% |
2,200,711
+506,160
| +30% | +$6.53M |
|
96
Lowe's Companies
LOW
$113B
| $29.1M | 0.18% |
606,105
-4,900
| -0.8% | -$228K |
|
|
SFE
97
DELISTED
Safeguard Scientifics, Inc.
SFE
| $29M | 0.18% |
1,393,901
+23,617
| +2% | +$475K |
|
98
Tapestry
TPR
$28.1B
| $28.8M | 0.18% |
843,523
-31,500
| -4% | -$1.35M |
|
99
Bausch Health
BHC
$1.66B
| $28.8M | 0.18% |
228,200
+97,700
| +75% | +$12.5M |
|
|
RTN
100
DELISTED
Raytheon Company
RTN
| $28.7M | 0.18% |
311,055
+1,353
| +0.4% | +$131K |
|
Similar funds
SAM
First Manhattan's Q2 2014 Portfolio in Review
As of Q2 2014, First Manhattan held 1,522 positions worth $15.8B, up 4% from $15.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
First Manhattan's Q2 2014 filing shows 71 new, 243 increased, 326 reduced and 55 closed positions. Its largest new stake was Navient: 627,603 shares worth $11.1M. The largest sale was Gen Digital, an estimated $90.2M.
By sector, the portfolio is most concentrated in Financials at 38% of assets, down from 39% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q2 2014 buy was Navient: 627,603 shares worth $11.1M.
- First Manhattan added most to Oracle in Q2 2014, an estimated $93.8M increase.
- First Manhattan's biggest Q2 2014 reduction was Gen Digital, cutting an estimated $90.2M.
- First Manhattan fully exited Cardiovascular Systems, Inc. in Q2 2014, selling an estimated $8.27M.
- First Manhattan's ten largest holdings make up 39% of its $15.8B portfolio in Q2 2014.
- First Manhattan opened 71 new positions and closed 55 in Q2 2014.
- First Manhattan's portfolio value rose 4% quarter-over-quarter to $15.8B.
Based on First Manhattan's 13F filing for Q2 2014, filed 14 Aug 2014.